ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...iscussant-abstracts-1183PD-1184PD-and-1557PD

Date: 27 Sep 2014
Presenter: Enriqueta Felip
Resources: Presentation, Webcast
Topic: Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...ults-from-the-phase-3-studies-ROMANA-1-and-2

Aim Cancer anorexia-cachexia syndrome is a common debilitating condition, characterized by decreased body weight, mainly lean body mass (LBM) and negatively impacts quality of life and prognosis.

Date: 27 Sep 2014
Presenter: Jennifer Temel
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...al-applications-for-microRNAs-in-lung-cancer

BodyNo abstract received at time of going to press

Date: 27 Sep 2014
Presenter: Carlo Croce
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-insights-for-sequencing-data-in-lung-cancer

Body Abstract:Cases of non-small-cell lung cancer (NSCC) carrying EGFR mutations have been shown to be hyperresponive to EGFR tyrosine kinase inhibtors. Chromosomal translocations and corresponding...

Date: 28 Sep 2014
Presenter: Kazuto Nishio
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Personalised Medicine, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...omes-and-cost-analysis-in-a-single-institute

AimHomeless people have limited access to medical care despite their higher risk for medical illnesses. The aim of our study was to describe the demographic and clinical features as well as the outcomes...

Date: 28 Sep 2014
Presenter: Koung Jin Suh
Resources: Abstract
Topics: Bioethics, Legal, and Economic Issues, Cancer in Special Situations, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...nduced-non-small-cell-lung-cancer-NSCLC-risk

Aim We analyzed the genome of individuals presenting extreme phenotypes of sensitivity and resistance to develop tobacco induced NSCLC to identify SNPs associated with these phenotypes.

Date: 28 Sep 2014
Presenter: Jose Luis Perez-Gracia
Resources: Abstract
Topics: Cancer Aetiology, Epidemiology, Prevention, Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...mong-inhabitants-of-the-South-Russian-region

AimEGFR mutations are predictors of both response to chemotherapy and survival regardless of the therapy and response to inhibitors of EGFR tyrosine kinase. EGFR mutations are observed in approximately...

Date: 28 Sep 2014
Presenter: Dmitriy Vodolazhskiy
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Personalised Medicine

http://oncologypro.esmo.org/Meeting-Resourc...-vintafolide-treatment-by-using-etarfolatide

AimCompanion diagnostics for cancer are frequently inaccurate as they are tissue based and do not account for heterogeneity of metastatic lesions and/or were obtained at remote time points.

Date: 28 Sep 2014
Presenter: Edward Garon
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Diagnostics, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...tion-of-liver-metastasis-LM-from-lung-cancer

AimAround 30% of non-small cell lung cancer (NSCLC) patients present LM during the disease course causing a negative clinical impact on survival and quality of life.

Date: 28 Sep 2014
Presenter: Eduardo Castanon Alvarez
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...EGFR-mutations-in-non-small-cell-lung-cancer

Aim Background: In non-small cell lung cancer (NSCLC), the association between common EGFR mutations (Del EX19/ L858R) with EGFR tyrosine kinase inhibitors (EGFR-TKIs) has been well established.

Date: 28 Sep 2014
Presenter: Alma Campos Parra
Resources: Abstract
Topics: Biomarkers, Lung and other Thoracic Tumours